Navigation Links
Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code
Date:4/2/2009

ooking statements. In order to comply with the terms of the safe harbor, Vermillion notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. There are no guarantees that Vermillion will succeed in its efforts to commercialize ovarian cancer or OVA1 diagnostics products in 2009 or during any other period of time. Factors that could cause actual results to materially differ include but are not limited to: (1) uncertainty in obtaining intellectual property protection for inventions made by Vermillion; (2) unproven ability of Vermillion to discover, develop, and commercialize ovarian cancer or OVA1 diagnostic products based on findings from its disease association studies; (3) unproven ability of Vermillion to discover or identify new protein biomarkers and use such information to develop ovarian cancer or OVA1 diagnostic products; (4) uncertainty as to whether Vermillion will be able to obtain any required regulatory approval of its ovarian cancer or OVA1 diagnostic products; (5) uncertainty of market acceptance of its ovarian cancer or OVA1 diagnostic products, including the risk that its products will not be competitive with products offered by other companies, or that users will not be entitled to receive adequate reimbursement for its products from third party payors such as private insurance companies and government insurance plans; (6) uncertainty that Vermillion will successfully license or otherwise successfully partner its products; (7) uncertainty that Vermillion will have the resources to successfully execute the contemplated reorganization; (8) uncertainty as to whether a long period operating under Chapter 11 may harm our business; (9) uncertainty regarding whether we will be able to obtain confirmation of our Chapter 11 plan; (10) uncertainty as to whether we will be able to emerge from bankruptcy without being liquidated;
'/>"/>
SOURCE Vermillion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
2. Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents
3. Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge
4. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
5. Renowned Stem Cell Researcher Files Study Results With Stemedica
6. Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
7. Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech
8. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
9. Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750
10. Tigris Pharmaceuticals Files IND Application for GGTI-2418
11. Panda Ethanols Hereford, Texas Subsidiary Files Voluntary Chapter 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... PARK, N.C. and PARIS ... research firm AgBiome, and Genective, key developer of ... accelerate the discovery of new generations of insect ... for insect control to counter the realities of ... with Genective, aligning AgBiome,s unique insect control technology ...
(Date:7/1/2015)...  Axovant Sciences Ltd. (NYSE:  AXON), a leading ... dementia, today announced that the company will host ... p.m. EDT following its presentation of RVT-101 clinical ... (AAIC). The event will include ... Lawrence Friedhoff , Chief Development Officer, will present ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... to combat pathogen transmission. CTI’ new Medical Joysticks have an impermeable molecular ... now have an operator control device that will increase healthcare worker safety and ...
(Date:6/30/2015)... ... June 30, 2015 , ... Park ... provide advanced scientific research into new classes of Nanoscale Graphene-based materials poised to ... as 'the wonder material of the 21st Century' by the researchers who were ...
Breaking Biology Technology:AgBiome and Genective collaborate to create novel insect-resistant crops 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 3How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 4
... International Holdings, Inc. (NYSE Amex: BONE ... graft material and antimicrobial coatings for medical applications, signed ... in the U.S. and Canada of Jeil,s LeForte System. ... implants used in craniomaxillofacial procedures, including trauma and reconstruction, ...
... Nov. 27, 2011  Candelis announced today that it has ... MSFT ) whereby Candelis, ASTRA cloud-hosted suite of services ... medical images and studies to patients, Microsoft HealthVault accounts ... a personal health application platform that lets consumers gather, ...
... Led by a group at the University of Maryland ... materials research and an age-old metallurgy technique to produce ... new class of sensors and micromechanical devices controlled by ... is notable, among other things, for not using rare-earth ...
Cached Biology Technology:Bacterin Signs Distribution Agreement with Jeil for 'LeForte Craniomaxillofacial System' 2Bacterin Signs Distribution Agreement with Jeil for 'LeForte Craniomaxillofacial System' 3Bacterin Signs Distribution Agreement with Jeil for 'LeForte Craniomaxillofacial System' 4Candelis and Microsoft Team Up to Empower Patients 2Candelis and Microsoft Team Up to Empower Patients 3New magnetic-field-sensitive alloy could find use in novel micromechanical devices 2
(Date:6/23/2015)... , June 23, 2015   Valencell, ... the results of a recent study that illustrates ... the wrist during activity. In a study conducted ... compared along with the Apple Watch against a ... heart rate during activity. The study demonstrated that ...
(Date:6/18/2015)... June 18, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market announces that its Wocket® ... on "Money on the Mark", scheduled to air on WABC ... June 20 th . The broadcast air- ... 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino Pereira ...
(Date:6/17/2015)... , June 17, 2015  Synaptics Inc. ... interface solutions, today announced that Xiaomi, one of ... Synaptics ® ClearPad ® family of ... driver integrated circuits (DDICs) for its latest smartphones, ... leveraging ClearPad for full in-cell display solutions and ...
Breaking Biology News(10 mins):Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... , , , WALL, ... Bulletin Board: BKYI), a leader in finger-based biometric ... of the world,s most respected security publications, named ... in the Access Control sub-category Biometrics. , (Logo: ...
... San Diego are developing new regenerative therapies for heart ... regenerative therapies for cardiovascular and other diseases are treated ... Diego on using adult stem cells to regenerate heart ... were presented this week in San Diego at the ...
... GAINESVILLE, Fla. University of Florida researchers have found ... dosage of a highly toxic, debilitating chemotherapy drug to achieve ... is needed before the therapy can be tested in patients, ... mice with established human tumors suggests that the addition of ...
Cached Biology News:BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Supportive materials will help regenerate heart tissue 2Small addition to cancer drug may make big difference 2Small addition to cancer drug may make big difference 3
Rabbit polyclonal to Presenilin 1, prediluted ( Abpromise for all tested applications). entrezGeneID: 5663 SwissProtID: P49768...
... MaV203 Competent Yeast Cells are designed ... (Figure 1). S. cerevisiae strain MaV203 contains ... genes for use with GAL4-based two-hybrid systems. ... mutations for selection of ProQuest bait and ...
Mouse monoclonal [CAT-1] to Chloramphenicol Acetyltransferase ( Abpromise for all tested applications)....
Component of HyperMu™ Insertion Kit...
Biology Products: